Literature DB >> 24136334

Elevated expression of the NLRP3 inflammasome in neutrophilic asthma.

Jodie L Simpson1, Simon Phipps, Katherine J Baines, Kevin M Oreo, Lakshitha Gunawardhana, Peter G Gibson.   

Abstract

Asthma is a heterogeneous inflammatory airways disorder where interleukin (IL)-1β is thought to be a key mediator, especially in the neutrophilic subtype of asthma. The generation of active IL-1β requires proteolytic cleavage typically mediated through the formation of a caspase-1-containing inflammasome. This study hypothesised that an IL-1β endotype associated with the nucleotide-binding domain, leucine-rich repeat-containing family protein (NLRP)3/apoptosis-associated speck-like protein containing a caspase-recruitment domain (ASC)/caspase-1 inflammasome is characteristic of patients with the neutrophilic subtype of asthma. Participants with asthma (n=85) and healthy controls (n=27) underwent clinical assessment, spirometry and sputum induction. Sputum was processed for differential cell count, gene expression and protein mediators. NLRP3 and caspase-1 expression was also determined by immunocytochemistry. Sputum macrophages were isolated (n=8) and gene expression of NLRP3 and IL-1β determined. There was significantly elevated gene expression of NLRP3, caspase-1, caspase-4, caspase-5 and IL-1β in participants with neutrophilic asthma. Protein levels of IL-1β were significantly higher in those with neutrophilic asthma and correlated with sputum IL-8 levels. Sputum macrophages, as well as sputum neutrophils in neutrophilic asthma, expressed NLRP3 and caspase-1 protein. NLRP3 inflammasome is upregulated in neutrophilic asthma and may regulate the inflammation process observed in this asthma phenotype through production of IL-1β.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24136334     DOI: 10.1183/09031936.00105013

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  85 in total

Review 1.  G Protein-Coupled Receptors in Asthma Therapy: Pharmacology and Drug Action.

Authors:  Stacy Gelhaus Wendell; Hao Fan; Cheng Zhang
Journal:  Pharmacol Rev       Date:  2020-01       Impact factor: 25.468

2.  ParadYm shift: Ym1 and Ym2 as innate immunological regulators of IL-17.

Authors:  Gaia Muallem; Christopher A Hunter
Journal:  Nat Immunol       Date:  2014-12       Impact factor: 25.606

3.  Extracellular DNA, Neutrophil Extracellular Traps, and Inflammasome Activation in Severe Asthma.

Authors:  Marrah E Lachowicz-Scroggins; Eleanor M Dunican; Annabelle R Charbit; Wilfred Raymond; Mark R Looney; Michael C Peters; Erin D Gordon; Prescott G Woodruff; Emma Lefrançais; Brenda R Phillips; David T Mauger; Suzy A Comhair; Serpil C Erzurum; Mats W Johansson; Nizar N Jarjour; Andrea M Coverstone; Mario Castro; Annette T Hastie; Eugene R Bleecker; Merritt L Fajt; Sally E Wenzel; Elliot Israel; Bruce D Levy; John V Fahy
Journal:  Am J Respir Crit Care Med       Date:  2019-05-01       Impact factor: 21.405

4.  The neonatal methylome as a gatekeeper in the trajectory to childhood asthma.

Authors:  Avery DeVries; Donata Vercelli
Journal:  Epigenomics       Date:  2017-03-21       Impact factor: 4.778

5.  Th2/Th17 reciprocal regulation: twists and turns in the complexity of asthma phenotypes.

Authors:  Jason P Lynch; Manuel A Ferreira; Simon Phipps
Journal:  Ann Transl Med       Date:  2016-10

Review 6.  Inflammasomes: a novel therapeutic target in pulmonary hypertension?

Authors:  Tara Elizabeth Scott; Barbara K Kemp-Harper; Adrian J Hobbs
Journal:  Br J Pharmacol       Date:  2018-06-27       Impact factor: 8.739

Review 7.  Novel approaches to the management of noneosinophilic asthma.

Authors:  Neil C Thomson
Journal:  Ther Adv Respir Dis       Date:  2016-02-28       Impact factor: 4.031

Review 8.  Mechanisms of non-type 2 asthma.

Authors:  Stephanie N Hudey; Dennis K Ledford; Juan Carlos Cardet
Journal:  Curr Opin Immunol       Date:  2020-11-04       Impact factor: 7.486

Review 9.  Inflammasomes link vascular disease with neuroinflammation and brain disorders.

Authors:  Nikolett Lénárt; David Brough; Ádám Dénes
Journal:  J Cereb Blood Flow Metab       Date:  2016-08-02       Impact factor: 6.200

10.  Role of NLRP3 Inflammasome in Eosinophilic and Non-eosinophilic Chronic Rhinosinusitis with Nasal Polyps.

Authors:  Hai Lin; Zhipeng Li; Dong Lin; Chunquan Zheng; Weitian Zhang
Journal:  Inflammation       Date:  2016-12       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.